YouthBio Therapeutics Inc.
YouthBio Therapeutics is pioneering tissue-specific gene therapies that leverage cellular reprogramming to rejuvenate tissues, improve organ function, and delay aging. Their mission is to harness the power of cellular reprogramming to restore youthful gene expression profiles in targeted cells, aiming for systemic rejuvenation through tailored therapies, starting with single-organ therapies for diseases like Alzheimer's. They focus on innovative research, developing gene delivery platforms, and advancing therapies that are safe, effective, and tissue-specific.
Industries
Nr. of Employees
small (1-50)
Products
Gene Therapy for Epigenetic Rejuvenation
A therapy that delivers genes responsible for epigenetic rejuvenation into target tissues, which can be periodically activated by a small molecule to rejuvenate the tissues.
Tissue-Specific Gene Therapies
Therapies that focus on rejuvenating specific tissues by restoring a more youthful gene expression profile in targeted cells.
Single-Organ Therapies
Initial therapies aimed at treating diseases in specific organs, such as brain diseases like Alzheimer's.
Combination Therapy for Systemic Rejuvenation
A future therapy aimed at periodically rejuvenating multiple key organs to achieve systemic rejuvenation and improve overall health.
Novel Rejuvenating Factors
Research and development of new factors that enhance the safety and efficacy of rejuvenation treatments.
Tissue-Specific Gene Delivery and Induction Platform
A platform being developed to enable more targeted and personalized gene therapy treatments.
Gene Therapy for Epigenetic Rejuvenation
A therapy that delivers genes responsible for epigenetic rejuvenation into target tissues, which can be periodically activated by a small molecule to rejuvenate the tissues.
Tissue-Specific Gene Therapies
Therapies that focus on rejuvenating specific tissues by restoring a more youthful gene expression profile in targeted cells.
Single-Organ Therapies
Initial therapies aimed at treating diseases in specific organs, such as brain diseases like Alzheimer's.
Combination Therapy for Systemic Rejuvenation
A future therapy aimed at periodically rejuvenating multiple key organs to achieve systemic rejuvenation and improve overall health.
Novel Rejuvenating Factors
Research and development of new factors that enhance the safety and efficacy of rejuvenation treatments.
Tissue-Specific Gene Delivery and Induction Platform
A platform being developed to enable more targeted and personalized gene therapy treatments.
Services
Preclinical development of tissue-specific gene therapies
Research and development of gene-based therapeutic approaches that apply partial reprogramming to rejuvenate specific tissues and treat age-related diseases, with emphasis on brain-targeted applications.
Collaborative research partnerships
Partnerships with academic labs and external investigators to perform joint studies evaluating partial reprogramming and rejuvenation in animal models.
Preclinical development of tissue-specific gene therapies
Research and development of gene-based therapeutic approaches that apply partial reprogramming to rejuvenate specific tissues and treat age-related diseases, with emphasis on brain-targeted applications.
Collaborative research partnerships
Partnerships with academic labs and external investigators to perform joint studies evaluating partial reprogramming and rejuvenation in animal models.
Expertise Areas
- Partial cellular reprogramming
- Tissue-specific gene therapy
- CNS and neurodegenerative therapeutic development
- Preclinical in vivo testing
Key Technologies
- Partial cellular reprogramming (transient expression of reprogramming factors)
- Tissue-specific inducible gene expression systems
- Small-molecule-controlled gene induction
- Viral vector-mediated gene delivery (inferred)